Trial ID 21195 | Maryland Oncology Hematology Trial ID 21195 – Maryland Oncology Hematology

Trial ID 21195

Trial Information - Phase N/A

Prospective multicenter observational study of patients with relapsed or refractory diffuse large B-cell lymphoma starting second- or third-line therapy and not receiving autologous stem cell transplant

Disease Specifics: (DLBCL)

Protocol ID: MOR208C414

Sponsor: Morphosys

Status: PENDING OPEN

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lymphoma

Investigator

Gaffar MD, Yousuf

Status

PENDING OPEN

Sponsor

Morphosys

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology